Select Region:
Select Language:

In this episode, QUIBIM CEO, Ángel Alberich-Bayarri discusses some of Quibim’s technological capabilities which makes real time clinical trial safety monitoring and efficacy assessments practical and possible.  Angel discusses the importance of analyzing biomarkers in the form of images and how this method can provide several advantages over the traditional blood biomarker analysis.  Join our mailing list to be notified of future webinars from Quibim!

Katherine Wilisch Ramírez

Subscribe